M. Koldas Et Al. , "Thrombin-activatable fibrinolysis inhibitor levels in patients with non-small-cell lung cancer," CLINICAL LUNG CANCER , vol.9, no.2, pp.112-115, 2008
Koldas, M. Et Al. 2008. Thrombin-activatable fibrinolysis inhibitor levels in patients with non-small-cell lung cancer. CLINICAL LUNG CANCER , vol.9, no.2 , 112-115.
Koldas, M., Gumus, M., Seker, M., Seval, H., Karaoglu, H., DANE, F., ... Kural, A.(2008). Thrombin-activatable fibrinolysis inhibitor levels in patients with non-small-cell lung cancer. CLINICAL LUNG CANCER , vol.9, no.2, 112-115.
Koldas, Macit Et Al. "Thrombin-activatable fibrinolysis inhibitor levels in patients with non-small-cell lung cancer," CLINICAL LUNG CANCER , vol.9, no.2, 112-115, 2008
Koldas, Macit Et Al. "Thrombin-activatable fibrinolysis inhibitor levels in patients with non-small-cell lung cancer." CLINICAL LUNG CANCER , vol.9, no.2, pp.112-115, 2008
Koldas, M. Et Al. (2008) . "Thrombin-activatable fibrinolysis inhibitor levels in patients with non-small-cell lung cancer." CLINICAL LUNG CANCER , vol.9, no.2, pp.112-115.
@article{article, author={Macit Koldas Et Al. }, title={Thrombin-activatable fibrinolysis inhibitor levels in patients with non-small-cell lung cancer}, journal={CLINICAL LUNG CANCER}, year=2008, pages={112-115} }